Author Question: We tend to like people most when self-disclosure is a. very intimate b. limited c. reciprocal ... (Read 36 times)

cool

  • Hero Member
  • *****
  • Posts: 570
We tend to like people most when self-disclosure is
 
  a. very intimate
  b. limited
  c. reciprocal
  d. immediate

Question 2

Which person in an unequitable relationship is likely to feel distressed?
 
  a. the underbenefited partner
  b. the overbenefited partner
  c. both the underbenefited and the overbenefited partner
  d. neither partner will feel distress until the relationship is ended



ryrychapman11

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: C

Answer to Question 2

Answer: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library